At present, the effects of Ang II in several categories of patients with vasoplegia have not been properly studied, such as patients with hemorrhagic shock, acute and acute-on-chronic liver failure, and patients with prothrombotic states, in whom the effects of Ang II remain controversial. Here, AGT is linked to chronic liver failure.